Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
169869-90-3
by reducing the growth of cells containing supernumerary centrosomes
which is a promising target for restricting cancer stem cell and cancer progression
1440898-61-2
The azido group will react with DBCO
ATN-161 Catalog No.:M8510-2 169869-90-3ATN 161 is a small peptide antagonist of integrin alpha5beta1 with potential antineoplastic activity. ATN 161 selectively binds to and blocks the receptor for integrin alpha5beta1, thereby preventing integrin alpha5beta1 binding. This receptor blockade may result in inhibition of endothelial cell cell interactions, endothelial cell matrix interactions, angiogenesis, and tumor progression. Integrin alpha5beta1 is expressed on endothelial cells and
US$ 85.00
US$ 85.00
US$ 75.00
US$ 38.00
US$ 38.00
US$ 38.00
US$ 99.00
US$ 44.00
US$ 85.00
US$ 360.00
US$ 38.00
US$ 38.00
US$ 44.00
US$ 38.00
US$ 38.00